Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Association of paraspinal muscle water-fat MRI-based measurements with isometric strength measurements.

Schlaeger S, Inhuber S, Rohrmeier A, Dieckmeyer M, Freitag F, Klupp E, Weidlich D, Feuerriegel G, Kreuzpointner F, Schwirtz A, Rummeny EJ, Zimmer C, Kirschke JS, Karampinos DC, Baum T.

Eur Radiol. 2018 Jul 16. doi: 10.1007/s00330-018-5631-8. [Epub ahead of print]

PMID:
30014202
2.

Thigh muscle segmentation of chemical shift encoding-based water-fat magnetic resonance images: The reference database MyoSegmenTUM.

Schlaeger S, Freitag F, Klupp E, Dieckmeyer M, Weidlich D, Inhuber S, Deschauer M, Schoser B, Bublitz S, Montagnese F, Zimmer C, Rummeny EJ, Karampinos DC, Kirschke JS, Baum T.

PLoS One. 2018 Jun 7;13(6):e0198200. doi: 10.1371/journal.pone.0198200. eCollection 2018.

3.

Continuous transversus abdominis plane block for analgesia in three dogs with abdominal pain.

Freitag FA, Bozak VL, do Carmo MP, Froes TR, Duque JC.

Vet Anaesth Analg. 2018 Jul;45(4):581-583. doi: 10.1016/j.vaa.2018.02.003. Epub 2018 Mar 6. No abstract available.

PMID:
29606557
4.

Randomised controlled trial on differential learning of toothbrushing in 6- to 9-year-old children.

Pabel SO, Freitag F, Hrasky V, Zapf A, Wiegand A.

Clin Oral Investig. 2018 Jul;22(6):2219-2228. doi: 10.1007/s00784-017-2313-x. Epub 2018 Mar 9.

PMID:
29524028
5.

Association of proton density fat fraction in adipose tissue with imaging-based and anthropometric obesity markers in adults.

Franz D, Weidlich D, Freitag F, Holzapfel C, Drabsch T, Baum T, Eggers H, Witte A, Rummeny EJ, Hauner H, Karampinos DC.

Int J Obes (Lond). 2018 Feb;42(2):175-182. doi: 10.1038/ijo.2017.194. Epub 2017 Aug 14.

6.

Cobalt-Catalyzed Alkylation of Secondary Alcohols with Primary Alcohols via Borrowing Hydrogen/Hydrogen Autotransfer.

Freitag F, Irrgang T, Kempe R.

Chemistry. 2017 Sep 7;23(50):12110-12113. doi: 10.1002/chem.201701211. Epub 2017 May 19.

PMID:
28452422
7.

Spinal cord interneurons expressing the gastrin-releasing peptide receptor convey itch through VGLUT2-mediated signaling.

Aresh B, Freitag FB, Perry S, Blümel E, Lau J, Franck MCM, Lagerström MC.

Pain. 2017 May;158(5):945-961. doi: 10.1097/j.pain.0000000000000861.

8.

Gait, posture and cognition in Parkinson's disease.

Barbosa AF, Chen J, Freitag F, Valente D, Souza CO, Voos MC, Chien HF.

Dement Neuropsychol. 2016 Oct-Dec;10(4):280-286. doi: 10.1590/s1980-5764-2016dn1004005. Review.

9.

The efficacy and safety of sumatriptan intranasal powder in adults with acute migraine.

Freitag FG, Shumate DA.

Expert Rev Neurother. 2016 Jul;16(7):743-7. doi: 10.1080/14737175.2016.1195687. Review.

PMID:
27260875
10.

Identification of a Neuronal Receptor Controlling Anaphylaxis.

Rogoz K, Aresh B, Freitag FB, Pettersson H, Magnúsdóttir EI, Larsson Ingwall L, Haddadi Andersen H, Franck MC, Nagaraja C, Kullander K, Lagerström MC.

Cell Rep. 2016 Jan 12;14(2):370-9. doi: 10.1016/j.celrep.2015.12.033. Epub 2015 Dec 31.

11.

Current and investigational drugs for the prevention of migraine in adults and children.

Freitag FG, Shumate D.

CNS Drugs. 2014 Oct;28(10):921-7. doi: 10.1007/s40263-014-0202-2. Review.

PMID:
25253573
12.

Medical management of adult headache.

Freitag FG, Schloemer F.

Otolaryngol Clin North Am. 2014 Apr;47(2):221-37. doi: 10.1016/j.otc.2013.11.002. Epub 2013 Dec 19. Review.

PMID:
24680490
13.
14.

A review of needle-free sumatriptan injection for rapid control of migraine.

Rothrock JF, Freitag FG, Farr SJ, Smith EF 3rd.

Headache. 2013 Sep;53 Suppl 2:21-33. doi: 10.1111/head.12183. Review.

PMID:
24024600
15.

SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.

Cady R, O'Carroll P, Dexter K, Freitag F, Shade CL.

Headache. 2014 Jan;54(1):67-79. doi: 10.1111/head.12211. Epub 2013 Sep 10.

PMID:
24021029
16.

Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.

Cady R, Nett R, Dexter K, Freitag F, Beach ME, Manley HR.

Headache. 2014 Jan;54(1):80-93. doi: 10.1111/head.12210. Epub 2013 Sep 10.

PMID:
24020994
17.

Why do migraines often decrease as we age?

Freitag FG.

Curr Pain Headache Rep. 2013 Oct;17(10):366. doi: 10.1007/s11916-013-0366-3. Review.

PMID:
23996722
18.

Author response.

Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C.

Neurology. 2013 Feb 26;80(9):868-9. No abstract available.

PMID:
23565553
19.

Managing and treating tension-type headache.

Freitag F.

Med Clin North Am. 2013 Mar;97(2):281-92. doi: 10.1016/j.mcna.2012.12.003. Epub 2012 Dec 27. Review.

PMID:
23419626
20.

Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E; Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Neurology. 2012 Apr 24;78(17):1346-53. doi: 10.1212/WNL.0b013e3182535d0c. Review.

21.

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E; Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Neurology. 2012 Apr 24;78(17):1337-45. doi: 10.1212/WNL.0b013e3182535d20. Review. Erratum in: Neurology. 2013 Feb 26;80(9):871.

22.

Spontaneously gapped ground state in suspended bilayer graphene.

Freitag F, Trbovic J, Weiss M, Schönenberger C.

Phys Rev Lett. 2012 Feb 17;108(7):076602. Epub 2012 Feb 13.

PMID:
22401232
23.

Effect of luminosity on color discrimination of dichromatic marmosets (Callithrix jacchus).

Freitag FB, Pessoa DM.

J Opt Soc Am A Opt Image Sci Vis. 2012 Feb 1;29(2):A216-22. doi: 10.1364/JOSAA.29.00A216.

PMID:
22330382
24.

Headache: advances in understanding and treatment.

Freitag FG.

Lancet Neurol. 2012 Jan;11(1):10-2. doi: 10.1016/S1474-4422(11)70270-8. No abstract available.

PMID:
22172613
25.

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.

Lipton RB, Varon SF, Grosberg B, McAllister PJ, Freitag F, Aurora SK, Dodick DW, Silberstein SD, Diener HC, DeGryse RE, Nolan ME, Turkel CC.

Neurology. 2011 Oct 11;77(15):1465-72. doi: 10.1212/WNL.0b013e318232ab65. Epub 2011 Sep 28.

PMID:
21956721
26.
27.

Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.

Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J.

Cephalalgia. 2011 Jan;31(1):18-30. doi: 10.1177/0333102410372427. Epub 2010 May 17.

PMID:
20974598
28.

Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine.

Rapoport AM, Freitag F, Pearlman SH.

CNS Drugs. 2010 Nov;24(11):929-40. doi: 10.2165/11317540-000000000-00000. Review.

PMID:
20932065
29.

From one electron to one hole: quasiparticle counting in graphene quantum dots determined by electrochemical and plasma etching.

Neubeck S, Ponomarenko LA, Freitag F, Giesbers AJ, Zeitler U, Morozov SV, Blake P, Geim AK, Novoselov KS.

Small. 2010 Jul 19;6(14):1469-73. doi: 10.1002/smll.201000291. No abstract available.

PMID:
20593379
30.

Superconductivity-enhanced conductance fluctuations in few-layer graphene.

Trbovic J, Minder N, Freitag F, Schönenberger C.

Nanotechnology. 2010 Jul 9;21(27):274005. doi: 10.1088/0957-4484/21/27/274005. Epub 2010 Jun 22.

PMID:
20571192
31.

Importance of botulinum toxin for prevention of migraine.

Freitag FG.

Expert Rev Neurother. 2010 Mar;10(3):339-40. doi: 10.1586/ern.10.11. No abstract available.

PMID:
20187855
32.

Needle-free subcutaneous sumatriptan (Sumavel DosePro): bioequivalence and ease of use.

Brandes JL, Cady RK, Freitag FG, Smith TR, Chandler P, Fox AW, Linn L, Farr SJ.

Headache. 2009 Nov-Dec;49(10):1435-44. doi: 10.1111/j.1526-4610.2009.01530.x. Epub 2009 Oct 22.

PMID:
19849720
33.

Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.

Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.

Headache. 2009 Sep;49(8):1153-62. doi: 10.1111/j.1526-4610.2009.01508.x.

PMID:
19719543
34.

Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.

Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J; CAPSS-277 Investigator Group.

Clin Ther. 2009 Mar;31(3):542-59. doi: 10.1016/j.clinthera.2009.03.020.

PMID:
19393844
35.

Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.

Cady RK, Freitag FG, Mathew NT, Elkind AH, Mao L, Fisher AC, Biondi DM, Finlayson G, Greenberg SJ, Hulihan JF.

Headache. 2009 Mar;49(3):350-63. doi: 10.1111/j.1526-4610.2009.01340.x. Epub 2009 Feb 11.

PMID:
19220503
36.

Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?

Wenzel RG, Tepper S, Korab WE, Freitag F.

Ann Pharmacother. 2008 Nov;42(11):1692-6. doi: 10.1345/aph.1L260. Epub 2008 Oct 28. Review.

PMID:
18957623
37.

Giant fluctuations and gate control of the g-factor in InAs nanowire quantum dots.

Csonka S, Hofstetter L, Freitag F, Oberholzer S, Schönenberger C, Jespersen TS, Aagesen M, Nygård J.

Nano Lett. 2008 Nov;8(11):3932-5. doi: 10.1021/nl802418w. Epub 2008 Oct 21.

PMID:
18937519
38.

Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate.

Silberstein S, Diener HC, Lipton R, Goadsby P, Dodick D, Bussone G, Freitag F, Schwalen S, Ascher S, Morein J, Greenberg S, Biondi D, Hulihan J.

Headache. 2008 Jul;48(7):1087-95. doi: 10.1111/j.1526-4610.2008.01185.x. Review.

PMID:
18687081
39.

Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.

Freitag F, Diamond M, Diamond S, Janssen I, Rodgers A, Skobieranda F.

Headache. 2008 Jun;48(6):921-30.

PMID:
18572432
40.

Effect of melasma on quality of life in a sample of women living in southern Brazil.

Freitag FM, Cestari TF, Leopoldo LR, Paludo P, Boza JC.

J Eur Acad Dermatol Venereol. 2008 Jun;22(6):655-62. doi: 10.1111/j.1468-3083.2007.02472.x. Epub 2008 Apr 10.

PMID:
18410339
41.

Pharmacoeconomic benefits of almotriptan in the acute treatment of migraine.

Freitag FG.

Expert Rev Pharmacoecon Outcomes Res. 2008 Apr;8(2):105-10. doi: 10.1586/14737167.8.2.105.

PMID:
20528399
42.

Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.

Freitag F, Smith T, Mathew N, Rupnow M, Greenberg S, Mao L, Finlayson G, Wright P, Biondi D; AEGIS Investigator Study Group.

Headache. 2008 Mar;48(3):341-54. doi: 10.1111/j.1526-4610.2007.01044.x.

PMID:
18302700
43.

Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials.

Adelman J, Freitag FG, Lainez M, Shi Y, Ascher S, Mao L, Greenberg S, Hulihan J.

Pain Med. 2008 Mar;9(2):175-85. doi: 10.1111/j.1526-4637.2007.00389.x.

PMID:
18298700
44.

The impact of topiramate on health-related quality of life indicators in chronic migraine.

Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ.

Headache. 2007 Nov-Dec;47(10):1398-408.

PMID:
18052949
45.

Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.

Freitag F, Taylor FR, Hamid MA, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.

Headache. 2008 Mar;48(3):368-77. Epub 2007 Nov 28.

PMID:
18047500
46.

Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.

Freitag FG, Diamond S, Diamond M, Urban G.

Headache. 2008 Feb;48(2):201-9. Epub 2007 Nov 28.

PMID:
18042229
47.

What causes dark circles under the eyes?

Freitag FM, Cestari TF.

J Cosmet Dermatol. 2007 Sep;6(3):211-5. Review.

PMID:
17760701
48.

The cycle of migraine: patients' quality of life during and between migraine attacks.

Freitag FG.

Clin Ther. 2007 May;29(5):939-949. doi: 10.1016/j.clinthera.2007.05.008. Review.

PMID:
17697913
49.

Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraine.

Freitag FG, Forde G, Neto W, Wang DZ, Schmitt J, Wu SC, Hulihan J.

J Am Osteopath Assoc. 2007 Jul;107(7):251-8.

PMID:
17682112
50.

Time course of adverse events most commonly associated with topiramate for migraine prevention.

Láinez MJ, Freitag FG, Pfeil J, Ascher S, Olson WH, Schwalen S.

Eur J Neurol. 2007 Aug;14(8):900-6.

PMID:
17662012

Supplemental Content

Loading ...
Support Center